Cabaletta Bio, Inc. (CABA) Tops Q2 EPS by 8c

Cabaletta Bio, Inc. (NASDAQ: CABA) reported Q2 EPS of ($0.45), $0.08 better than the analyst estimate of ($0.53).

For earnings history and earnings-related data on Cabaletta Bio, Inc. (CABA) click here.

You May Also Be Interested In

• Pelagos Insurance Capital (PLGO) PT Raised to $28 at Citizens on Rising Book Value
• Ionis Pharmaceuticals (IONS) reaffirms guidance
• Morgan Stanley downgrades Chinese luxury auto dealers on weak demand